US 3D printer OEM Carbon has announced the development of an experimental bioresorbable material with demonstrable biocompatibility in vivo.
During testing, the in-house developed elastomer is said to have been designated ‘non-toxic,’ while being customizable to ensure that it’s fully absorbed into host tissues. As such, Carbon says the resin could be ideal for 3D printing lattices with applications in tissue repair, wound dressing or the creation of nerve conduits.
“We’re very pleased to announce that Carbon’s developmental bioabsorbable elastomer platform has demonstrated biocompatibility in vivo,” said Jason Rolland, SVP of Materials at Carbon. “These intricate structures made with Carbon Digital Light Synthesis (DLS) technology may hold the key to addressing the longstanding challenge of optimizing the mechanical properties and degradation rate of an…
